Abstract:Abstract The somatic evolution of cancer depends on the rate at which new mutations are acquired, as well as the selective pressure acting on them. Further, mutual exclusivity or co-occurrence of somatic variants suggests that current somatic variants can exert antagonistic or synergistic epistatic effects on the selection of new mutations, contributing to a complex landscape of evolutionary trajectories. However, quantifying these epistatic effects—which are essential to estimation of the trajectory of likely cancer genotoypes—has been a challenge, especially for higher-order epistatic effects. To estimate these epistatic effects, we have developed a continuous-time Markov chain model that enables the estimation of mutation origination and fixation, dependent on somatic cancer genotype. Coupling the continuous-time Markov chain model with a mutation-rate deconvolution approach, we have estimated the underlying mutation rates and selection intensities across trajectories of oncogenesis. Specifically, we report the mutation rates, selection intensities, and consequent variant fluxes for lung adenocarcinoma, informed by a compilation of samples from multiple data sets including The Cancer Genome Atlas and the AACR Project GENIE. Furthermore, we compare smoker and nonsmoker tumor cohorts describing the distinct evolutionary trajectories jointly, influenced by differential mutation and also by the differential physiological effects that smoking can have on the selective regime of lung tissue. Our approach enables inference of the most likely routes of site-specific variant evolution, as well as estimation of the selection strength operating on each step along the route—a key component of what we need to know to prioritize, develop, and implement personalized cancer therapies. Citation Format: Jorge A. Alfaro-Murillo, Krishna Dasari, Jeffrey P. Townsend. Detecting epistatic effects among somatic cancer mutations across oncogenesis [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Translating Cancer Evolution and Data Science: The Next Frontier; 2023 Dec 3-6; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_2):Abstract nr IA014.

Evolutionary dependency of cancer mutations in gene pairs inferred by nonsynonymous-synonymous mutation ratios

Functional variomics and network perturbation: connecting genotype to phenotype in cancer

Integrated Multi‐omics Data Analyses for Exploring the Co‐occurring and Mutually Exclusive Gene Alteration Events in Colorectal Cancer

Population-based statistical inference for temporal sequence of somatic mutations in cancer genomes

A Network Of Cancer Genes With Co-Occurring And Anti-Co-Occurring Mutations

Mutation-Profile-Based Methods for Understanding Selection Forces in Cancer Somatic Mutations: A Comparative Analysis

Defining relative mutational difficulty to understand cancer formation

Identifying Candidate Cancer Genes by Finding Co-Occurring Mutations in Cancer Mutation Profiles

A Gene Gravity Model for the Evolution of Cancer Genomes: A Study of 3,000 Cancer Genomes across 9 Cancer Types

Mutation frequency and copy number alterations determine prognosis and metastatic tropism in 60,000 clinical cancer samples

The shaping of cancer genomes with the regional impact of mutation processes

Co-occurring Mutations in Different Genes Can Fuel Oncogenic Signaling and Serve as Metastatic Tumor Markers

Analytical Methods for Inferring Functional Effects of Single Base Pair Substitutions in Human Cancers

Abstract IA014: Detecting epistatic effects among somatic cancer mutations across oncogenesis

Joint analysis of mutational and transcriptional landscapes in human cancer reveals key perturbations during cancer evolution

e-MutPath: computational modeling reveals the functional landscape of genetic mutations rewiring interactome networks

Remarkable Difference of Somatic Mutation Patterns Between Oncogenes and Tumor Suppressor Genes.

Genetic Progression and the Waiting Time to Cancer

Prediction of metabolites associated with somatic mutations in cancers by using genome-scale metabolic models and mutation data

An Evolutionary Perspective On Single-Nucleotide Polymorphism Screening In Molecular Cancer Epidemiology

A tug-of-war between driver and passenger mutations in cancer and other adaptive processes